Biontech Se Sponsored Adr Stock News

MISE À DAY Pfizer and BioNTech announced on Tuesday that they have asked the United States Medicines Agency to authorize an additional booster dose of their Covid-19 vaccine for people aged 65 and over. This request is made on the basis of data coming from Israel and analyzed at the time the Omicron variant was […] The post Pfizer asks the United States to authorize a second booster dose against COVID-19 first appeared on The Bobr Times .

WASHINGTON (AP) — Pfizer and its partner BioNTech asked U.S. regulators Tuesday to authorize an additional booster dose of their COVID-19 vaccine for seniors, saying data from Israel suggests older adults would benefit. Currently the U.S.

Pfizer and partner BioNTech file application for people 65 years and older

The vaccine makers asked regultors to authorize another booster shot of their Covid-19 vaccine for adults aged 65 and older who have already gotten one booster dose of an approved vaccine.

Pfizer and BioNTech could seek emergency use authorization from the US Food and Drug Administration for a second booster shot of their Covid-19 vaccine for people 65 and older as soon as Tuesday, in news first reported by The Washington Post.

Pfizer Inc and its German partner BioNTech SE will seek emergency use authorization for a second booster shot of their COVID-19 vaccine for people aged 65 and older, the Washington Post reported on Tuesday.

Pfizer (PFE) and BioNTech (BNTX) will seek to expand authorization of their COVID-19 vaccine to include a second booster shot for adults 65 years and older.

NEW YORK , March 15, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for RGEN, ZEN, UAL, DLTR, and BNTX. … Full story available on Benzinga.com

Gainers Volt Information Sciences, Inc. (NYSE: VOLT ) shares surged 94.7% to close at $5.88 on Monday after the company announced it would be acquired for $6 per share. Incannex Healthcare Limited (NASDAQ: IXHL ) surged 54% to settle at $22.90. Incannex Healthcare recently completed a preliminary analysis of data from its Phase 2 trial of a cannabinoid combination product, IHL-42X, for obstructive sleep apnoea (OSA). Red Cat Holdings, Inc. (NASDAQ: RCAT ) rose 48.4% to close at $2.73 after the company announced its subsidiary Teal Drones has been selected by the Department of Defense''s Defense Innovation Unit and U.S. Army to compete in the Short Range Reconnaissance Tranche 2 Program of Record. Q&K International Group Limited (NASDAQ: QK ) jumped 37.6% to settle at $1.6920. Q&K shares recently announced an ADS ratio change. AgriFORCE Growing Systems, Ltd. (NASDAQ: AGRI ) shares gained 25.7% to close at $3.96. Turquoise Hill Resources Ltd. (NYSE: TRQ ) jumped 31.9% to settle at $26.55 after Rio Tinto proposed to acquire the company at C$34 per share.

Shares of Moderna, BioNTech, Pfizer, Johnson & Johnson and Novavax rose on Monday as China battles its worst Covid outbreak in two years.

BioNTech SE - ADR (NASDAQ: BNTX ) shares are trading higher by 14.8% at $155.65. Strength is possibly due to a spike in COVID-19 cases in China, which could lift vaccine sector sentiment. A spike … Full story available on Benzinga.com

GeoVax Labs Inc (NASDAQ: GOVX ) has engaged CATO SMS to manage its two ongoing Phase 2 trials of its COVID-19 vaccine candidate, GEO-CM04S1. One is testing the safety and effectiveness of GEO-CM04S1 compared to the Pfizer Inc (NASDAQ: PFE ) / BioNTech SE (NASDAQ: BNTX ) in immunosuppressed patients with blood cancer. The other trial is testing GEO-CM04S1 as a booster in healthy adults … Full story available on Benzinga.com

GeoVax Labs Inc (NASDAQ: GOVX ) has engaged CATO SMS to manage its two ongoing Phase 2 trials of its COVID-19 vaccine candidate, GEO-CM04S1. One is testing the safety and effectiveness of GEO-CM04S1 compared to the Pfizer Inc (NASDAQ: PFE ) / BioNTech SE (NASDAQ: BNTX ) in immunosuppressed patients with blood cancer. The other trial is testing GEO-CM04S1 as a booster in healthy adults … Full story available on Benzinga.com

The broader stock market bounce and news from China are fueling gains for all four vaccine stocks.